心血管疾病中的BCAA代谢阻滞:致病机制和干预措施
Yun Yin1, Huimin Li1, Qingxun Hu2
1Department of Pharmacy, Tongji Hospital, School of Medicine, Tongji University, 389 Xincun Road, Shanghai, 200065, People's Republic of China.
概括
分链氨基酸 (BCAA) 对心脏健康至关重要. 不调节的BCAA代谢有助于心血管疾病 (CVD),需要针对性干预以获得更好的心脏健康结果.
科学领域:
- 生物化学 生物化学
- 代谢途径 代谢途径
- 心血管生理学心血管生理学
背景情况:
- 分支链氨基酸 (BCAA) 氨酸,异氨酸和氨酸是必需的营养素.
- BCAA的代谢平衡对于保持心血管健康至关重要.
- 越来越多的BCAA失调与心血管疾病 (CVD) 病原发生有关.
研究的目的:
- 审查BCAA的饮食来源,生理作用和代谢途径.
- 探索BCAA积累和检测方法的机制.
- 突出BCAA及其代谢物对心血管疾病的监管影响.
主要方法:
- 关于BCAA代谢和心血管健康的文献综合.
- 分析驱动BCAA积累的机制.
- 评估当前的BCAA检测技术.
- 探索针对BCAA代谢的治疗策略.
主要成果:
- BCAA及其代谢物通过多个途径显著影响心血管疾病.
- BCAA的积累是由各种生理和病理机制驱动的.
- 对BCAA和BCKA和3-HIB等代谢物的联合监测很重要.
结论:
- 涉及饮食调节,酶管理,mTOR途径向和天然化合物的组合策略可以抵消BCAA失调引起的心血管病理.
- 了解BCAA代谢为心血管疾病研究提供了一个框架.
- 精密心脏病学的进步可以利用BCAA代谢途径向.
相关概念视频
Coronary Artery Disease I: Introduction
868
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
868
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Overview of Lipid Metabolism
4.8K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Cardiomyopathy V: Interprofessional Care
326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
529
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
529

